As part of the French Presidency of the Council of the European Union (FPEU ), ANSES will be organising and taking part in several events involving counterpart agencies and scientific and institutional partners. Discover some of the highlights planned for the first half of 2022, covering a wide range of topics including veterinary medicinal products, food and chemicals.
What does the new European regulation on veterinary medicinal products change?
The new European regulation on veterinary pharmaceuticals came into force on 28 January 2022. The Director of the French Agency for Veterinary Medicinal Products (ANMV), Jean-Pierre Orand, assesses what will change.
ANSES at the 2022 Paris International Agricultural Show
Tous les jours de 9h à 19h
Parc des expositions - Porte de Versailles, Paris - Hall 4, Allée B, stand n°118
Public : oui
Porte de Versailles, Paris 15e
Food is one of the pillars of our health. And yet an imbalanced diet or contaminated food can expose us to immediate risks and chronic diseases. As France's leading health agency on this topic, ANSES looks forward to seeing you at the 2022 Paris International Agricultural Show, at its stand dedicated to safe and healthy food. You will have the opportunity to discover how ANSES’s researchers and scientific experts work to protect us from risks ‘from farm to fork’, and help us adopt good daily hygiene and nutrition practices.
Phytotherapy and aromatherapy: adapting risk assessment in veterinary medicine
Herbal preparations (phytotherapy) and essential oils (aromatherapy) are increasingly being used as alternatives to other “allopathic” medicinal products for the treatment of animals. This is true even for food-producing animals. If the products used have a therapeutic purpose, they are considered veterinary medicinal products.This means it should be possible to guarantee there is no risk to consumers of foods derived from treated animals. However, it is complicated to implement the current regulations to assess this risk for herbal medicinal products. ANSES therefore issued an internal request to propose a specific assessment methodology for herbal veterinary medicinal products.
The CNDP and ANSES forge a partnership to better inform and involve the public
As part of their respective commitments at the service of high-quality public debate on environmental issues, the National Commission for Public Debate (CNDP) and the French Agency for Food, Environmental and Occupational Health & Safety (ANSES) are entering into a partnership to improve the information provided to the public and support civic participation.
Human hormonal treatments: be careful not to expose your pets
In dogs and cats, repeated contact with their owner’s topical hormone replacement therapy can cause hormonal problems. Following reports of adverse effects in several European countries, ANSES-ANMV (French Agency for Veterinary Medicinal Products) is inviting owners to apply these medications with the necessary precautions to avoid exposing their pets.
A partnership to better control bacteria in food processing facilities
The presence of Listeria and Salmonella bacteria in food processing facilities poses several problems: pathogenic for humans, these bacteria are capable of persisting for a long time in the environment and resisting treatment with biocidal products. The Actia Fastypers Joint Technology Unit (UMT) was recently created by the French Ministry of Agriculture for a five-year period, in order to work on these issues. It brings together research teams (ANSES, INRAE) and agro-industrial technical institutes (Actalia, for the dairy sector, and the French Pork and Pig Institute (IFIP)).
Health risk assessment: ANSES renews ten of its expert groups
In order to assess health risks, ANSES relies on collective, independent expert appraisals, conducted by multidisciplinary groups of scientific experts that it coordinates. It is now issuing a call for applications to renew ten of these expert groups in the following fields: human food and nutrition, animal health and welfare, and plant health. Nominations for these groups, open to scientists from a wide variety of disciplines, must be submitted online in French until 31 March 2022.
Electronic cigarettes: which inhaled substances should be monitored as a priority?
Electronic cigarettes have been widely adopted by part of the population, yet the health risks potentially associated with the inhalation of the substances emitted by these devices have yet to be assessed in detail. ANSES has drawn up a list of substances to be studied as a priority in order to assess the risks associated with their inhalation.